From 2014 to 2018, private insurance claim lines1 for non-hospital-based provider-to-patient telehealth grew 1393%, according to a new white paper on telehealth from FAIR Health, a national, independent nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information. The study draws on data from FAIR Health’s comprehensive repository of over 29 billion private healthcare claim records—the largest in the country.
This increase was the largest of 4 types of telehealth studied, and a larger increase than that for telehealth overall. The increase was greater in urban than rural areas. Claim lines for non-hospital-based provider-to-patient telehealth increased 1227% in urban areas, and 897% in rural areas.
The 4 types of telehealth—the remote provision of clinical services through telecommunications technology—studied in the white paper were:
The telehealth white paper expands on a previous FAIR Health white paper that reported on telehealth and other alternative venues of care, such as urgent care centers and retail clinics. The new white paper provides additional details, delving into the different types of telehealth, the most common telehealth diagnostic categories and what happens to patients after a telehealth visit.
Among the findings of the new study:
Claim lines related to telehealth overall grew 624% from 2014 to 2018 (Table 1).
Table 1. Claim Lines With Telehealth Usage by Type as a Percentage of All Medical Claim Lines, 2014-2018
Source: FAIR Health
In 2018, non-hospital-based provider-to-patient telehealth accounted for 84% of all telehealth claim lines, compared with 52% in 2014.
In the period 2014-2018, the age group most associated with telehealth overall were those 31 to 40 years of age, who accounted for 21% percent of the distribution of all telehealth claim lines ( Table 2). But most of the claim lines (82%) for discharge-related provider-to-patient telehealth were associated with those 51 years of age and older.
Table 2. All Telehealth Claim Lines by Age Group, 2014-2018
Source: FAIR Health
Sixty-five percent of all telehealth claim lines in the period 2014-2018 were associated with females. But for telehealth visits associated with a hospital discharge, 53% of claim lines were submitted for females.
The top 3 reasons individuals sought treatment from a provider via non-hospital-based telehealth, from most to least common, were acute upper respiratory infections, mood (affective) disorders, and anxiety and other nonpsychotic mental disorders (Table 3).
Table 3. Distribution of Non-Hospital-Based Provider-to-Patient Telehealth Claim Lines by Mid-Level Diagnostic Category, 2018
Source: FAIR Health
In 2018, the telehealth diagnosis with the highest rate of patients who had an in-person visit within 15 days of a non-hospital-based provider-to-patient telehealth visit for the same or a very similar diagnosis was heart failure (Table 4).
Table 4. Top Telehealth Diagnoses for Which a Patient Had an In-Person Follow-Up Visit with a Provider for the Same or a Very Similar Diagnosis within 15 Days of a Non-Hospital-Based Provider-to-Patient Telehealth Visit, 2018
Source: FAIR Health
As telehealth continues its rapid growth, we are pleased to use our unparalleled data repository to uncover layers that have been difficult to study. We offer the information in this report for the benefit of all healthcare stakeholders with an interest in the emergence and contours of telehealth.
Note
1. A claim line is an individual procedure or service listed on an insurance claim.
Author Information
Robin Gelburd, JD, is the president of FAIR Health, a national, independent nonprofit organization with the mission of bringing transparency to healthcare costs and health insurance information. FAIR Health possesses the nation’s largest collection of private healthcare claims data, which includes over 29 billion claim records contributed by payors and administrators who insure or process claims for private insurance plans covering more than 150 million individuals. Certified by the Centers for Medicare & Medicaid Services (CMS) as a national Qualified Entity, FAIR Health also receives data representing the experience of all individuals enrolled in traditional Medicare Parts A, B and D; FAIR Health houses data on Medicare Advantage enrollees in its private claims data repository. Robin is a nationally recognized expert on healthcare policy, data and transparency.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More